A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/203 (2006.01) A61K 9/14 (2006.01) A61K 9/51 (2006.01) A61K 47/34 (2006.01) A61K 49/04 (2006.01)
Patent
CA 2108192
The present invention is directed to a composition comprised of nanoparticles having tyloxapol adsorbed on the surface thereof. In a preferred embodiment, said nanoparticle contains a diagnostic or therapeutic agent therein. In a further preferred embodiment, the nanoparticles contain a further surface modifier associated therewith. This invention further discloses a method of making nanoparticles having tyloxapol adsorbed on the surface, said method comprising contacting said nanoparticles with tyloxapol for a time and under conditions sufficient to provide a nanoparticle-tyloxapol composition. The present invention is also directed to a method of diagnosis comprising administering to a mammal a contrast effective amount of particles of nanoparticles having tyloxapol adsorbed on the surface thereof, and generating a diagnostic image of said mammal.
Elan Pharma International Limited
Fetherstonhaugh & Co.
Sterling Winthrop Inc.
LandOfFree
Use of tyloxapol as a nanoparticle stabilizer and dispersant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tyloxapol as a nanoparticle stabilizer and dispersant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tyloxapol as a nanoparticle stabilizer and dispersant will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952198